Feb 6, 2026, “HLA-DQB1*03:01 and HLA-DQA1*05:05 as key genetic determinants of infliximab response and immunogenicity in Japanese patients with inflammatory bowel disease” has been published in Journal of Gastroenterology.
Feb 6, 2026, “HLA-DQB1*03:01 and HLA-DQA1*05:05 as key genetic determinants of infliximab response and immunogenicity in Japanese patients with inflammatory bowel disease” has been published in Journal of Gastroenterology.